Publikationen aus 2007

Autorinnen und Autoren des Paul-Ehrlich-Instituts sind durch Fettdruck kenntlich gemacht. Wenn Online-Abstracts oder Volltexte zu den Publikationen verfügbar sind, so sind diese verlinkt.

Andersson K, Ballmer-Weber BK, Cistero-Bahima A, Östling J, Lauer I, Vieths S, Lidholm J (2007): Enhancement of hazelnut extract for IgE testing by recombinant allergen spiking.
Allergy 62: 897-904.

Antonis AFG, van der Most RG, Suezer Y, Stockhofe-Zurwieden N, Daus F, Sutter G, Schrijver RS (2007): Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
Vaccine 25: 4818-4827.

Asero R, Ballmer-Weber BK, Beyer K, Conti A, Dubakiene R, Fernandez-Rivas M, Hoffmann-Sommergruber K, Lidholm J, Mustakov T, Oude Elberink JN, Pumphrey RS, Stahl Skov P, van Ree R, Vlieg-Boestra BJ, Hiller R, Hourihane JO, Kowalski M, Papadopoulos NG, Wal JM, Mills EN, Vieths S (2007): IgE-Mediated food allergy diagnosis: Current status and new perspectives.
Mol Nutr Food Res 51: 135-147.

Bach P, Kamphuis E, Odermatt B, Sutter G, Buchholz CJ, Kalinke U (2007): Vesicular stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies.
J Immunol 178: 5839-5847.

Ballmer-Weber BK, Holzhauser T, Scibilia J, Mittag D, Zisa G, Ortolani C, Oesterballe M, Poulsen LK, Vieths S, Bindslev-Jensen C (2007): Clinical characteristics of soybean allergy in Europe: A double-blind, placebo-controlled food challenge study.
J Allergy Clin Immunol 119: 1489-1496.

Bayerer B, Savidou I, Engelbergs J, Wissmann A, Limmroth V, Diener HC (2007): Migraine: Is it a Question of the Genes.
Akt Neurol 34: 444-447.

Beer F, Kuo CH, Morohoshi K, Goodliffe J, Munro P, Aye CC, Dawson M, Richardson RM, Jones LH, Ikeda Y, Nakamura T, Toda M, Flynn T, Ohbayashi M, Miyazaki D, Ono SJ (2007): Role of beta-chemokines in mast cell activation and type I hypersensitivity reactions in the conjunctiva: in vivo and in vitro studies.
Immunol Rev 217: 96-104.

Blakqori G, Delhaye S, Habjan M, Blair CD, Sánchez-Vargas I, Olson KE, Attarzadeh-Yazdi G, Fragkoudis R, Kohl A, Kalinke U, Weiss S, Michiels T, Staeheli P, Weber F (2007): La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.
J Virol 81: 4991-4999.

Cosma A, Nagaraj R, Staib C, Diemer C, Wopfner F, Schätzl H, Busch DH, Sutter G, Goebel FD, Erfle V (2007): Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIVType 1-infected individuals undergoing HAART.
AIDS Res Hum Retroviruses 23: 782-793.

Demirel O, Waibler Z, Kalinke U, Grunebach F, Appel S, Brossart P, Hasilik A, Tampe R, Abele R (2007): Identification of a lysosomal peptide transport system induced during dendritic cell development.
J Biol Chem 282: 37836-37843.

Denner J, Tönjes RR (2007): International symposium on xenotransplantation.
Xenotransplantation 14: 366-373.

DiCarlo A, Möller P, Lander A, Kolesnikova L, Becker S (2007): Nucleocapsid formation and RNA synthesis of Marburg virus is dependent on two coiled coil motifs in the nucleoprotein.
Virol J 4: 105.

Dietz K, Raddatz G, Wallis J, Müller N, Zerr I, Duerr HP, Lefévre H, Seifried E, Löwer J (2007): Blood Transfusion and Spread of Variant Creutzfeldt-Jakob Disease.
Emerg Infect Dis 13: 89-96.

Dzagnidze A, Katsarava Z, Makhalova J, Liedert B, Yoon MS, Kaube H, Limmroth V, Thomale J (2007): Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy.
J Neurosci 27: 9451-9457.

El-Gogo S, Staib C, Meyr M, Erfle V, Sutter G, Adler H (2007): Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
Vaccine 25: 3934-3945.

Gabriel G, Abram M, Keiner B, Wagner R, Klenk HD, Stech J (2007): Differential polymerase activity in avian and mammalian cells determines host range of influenza virus.
J Virol 81: 9601-9604.

Gasteiger G, Kastenmuller W, Ljapoci R, Sutter G, Drexler I (2007): Crosspriming of cytotoxic T-cells dictates antigen requisites for MVA vector vaccines.
J Virol 81: 11925-11936.

Gerlich WH, Wagner FF, Chudy M, Harritshoj LH, Lattermann A, Wienzek S, Glebe D, Saniewski M, Schuttler CG, Wend UC, Willems WR, Bauerfeind U, Jork C, Bein G, Platz P, Ullum H, Dickmeiss E (2007): HBsAg non-reactive HBV infection in blood donors: Transmission and pathogenicity.
J Med Virol 79: S32-S36.

Gubesch M, Theler B, Dutta M, Baumer B, Mathis A, Holzhauser T, Vieths S, Ballmer-Weber BK (2007): Strategy for allergenicity assessment of 'natural novel foods': clinical and molecular investigation of exotic vegetables (water spinach, hyacinth bean and Ethiopian eggplant).
Allergy 62: 1243-1250.

Hakansson L, Dalgleish A, Kallen KJ, Schuessler-Lenz M (2007): Vaccines: A rapidly evolving technology – Are the hurdles being addressed?.
Eur J Cancer Supplements 5: 29-32.

Hartz C, San Miguel-Moncin MM, Cistero-Bahima A, Fötisch K, Metzner KJ, Fortunato D, Lindholm J, Vieths S, Scheurer S (2007): Molecular characterisation of Lac s 1, the major allergen from lettuce (Lactuca sativa).
Mol Immunol 44: 2820-2830.

Hoff M, Son DY, Gubesch M, Ahn K, Lee SI, Vieths S, Goodman RE, Ballmer-Weber BK, Bannon GA (2007): Serum testing of genetically modified soybeans with special emphasis on potential allergenicity of the heterologous protein CP4 EPSPS.
Mol Nutr Food Res 51: 946-955.

Hoffmann A, Mergel A, Cußler K (2007): Pharmakovigilanzreport Tierimpfstoffe. Zur Statistik der im Jahr 2006 im Paul-Ehrlich-Institut eingegangenen Meldungen.
Deutsches Tierärzteblatt 12/2007: 1536-1539.

Ivaskevicius V, Seitz R, Kohler HP, Schroeder V, Muszbek L, Ariens RAS, Seifried E, Oldenburg J, The Study Group (2007): International Registry on Factor XIII Deficiency: A basis formed mostly on European data.
Thromb Haemost 97: 914-921.

Kaul S, Lüttkopf D, Kastner B, Vogel L, Höltz G, Vieths S, Hoffmann A (2007): Mediator release assays based on human or murine IgE in allergen standardization.
Clin Exp Allergy 37: 141-150.

Kegel B, Behrensdorf-Nicol HA, Bonifas U, Silberbach K, Klimek J, Krämer B, Weißer K (2007): An in vitro assay for detection of tetanus neurotoxin activity: Using antibodies for recognizing the proteolytically generated cleavage product.
Toxicol in Vitro 21: 1641-1649.

Koerner I, Kochs G, Kalinke U, Weiss S, Staeheli P (2007): Protective Role of Beta Interferon in Host Defense against Influenza A Virus.
J Virol 81: 2025-2030.

Kreijtz JHCM, Suezer Y, van Amerongen G, de Mutsert G, Schnierle BS, Wood JM, Kuiken T, Fouchier RAM, Löwer J, Osterhaus ADME, Sutter G, Rimmelzwaan GF (2007): Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.
J Infect Dis 195: 1598-1606.

Kretzschmar E, Chudy M, Nübling CM, Ross RS, Kruse F, Trobisch H (2007): First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays.
Vox Sang 92: 297-301.

Kwok T, Zabler D, Urman S, Rhode M, Hartig R, Wessler S, Misselwitz R, Berger J, Sewald N, König W, Backert S (2007): Helicobacter exploits integrin for type IV secretion and kinase activation.
Nature 449: 862-866.

Lantermann M, Schwantes A, Sliva K, Sutter G, Schnierle BS (2007): Vaccinia virus double-stranded RNA-binding protein E3 does not interfere with siRNA-mediated gene silencing in mammalian cells.
Virus Res 126: 1-8.

Lauer I, San Miguel-Moncin MM, Abel T, Foetisch K, Hartz C, Fortunato D, Cistero-Bahima A, Vieths S, Scheurer S (2007): Identification of a plane pollen lipid transfer protein (Pla a 3) and its immunological relation to the peach lipid-transfer protein, Pru p 3.
Clin Exp Allergy 37: 261-269.

Liedert B, Bassus S, Schneider C, Kalinke U, Löwer J (2007): Safety of Phase I clinical trials with monoclonal antibodies in Germany - the regulatory requirements viewed in the aftermath of the TGN1412 disaster.
Int J Clin Pharmacol Ther 45: 1-9.

Lin J, Renault N, Haas H, Schramm G, Vieths S, Vogel L, Falcone FH, Alcocer MJ (2007): A novel tool for the detection of allergic sensitization combining protein microarrays with human basophils.
Clin Exp Allergy 37: 1854-1862.

Marzi A, Möller P, Hanna SL, Harrer T, Eisemann J, Steinkasserer A, Becker S, Baribaud F, Pöhlmann S (2007): Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR.
J Infect Dis 196: S237-S246.

Montag T, Spreitzer I, Löschner B, Unkelbach U, Flory E, Sanzenbacher R, Schwanig M, Schneider CK (2007): Safety testing of cell-based medicinal products: Opportunities for the monocyte activation test for pyrogens.
ALTEX 24: 81-89.

Muckenfuss H, Cichutek K, Flory E (2007): Current Regulation of Advanced Therapy Medicinal Products in the European Union.
J Intern Biotechnology Law 4: 16-20.

Muckenfuss H, Kaiser JK, Krebil E, Battenberg M, Schwer C, Cichutek K, Münk C, Flory E (2007): Sp1 and Sp3 regulate basal transcription of the human APOBEC3G gene.
Nucleic Acids Res 35: 3784-3796.

Müller S, Möller P, Bick MJ, Wurr S, Becker S, Günther S, Kümmerer BM (2007): Inhibition of filovirus replication by the zinc finger antiviral protein.
J Virol 81: 2391-2400.

Münk C, Zielonka J, Constabel H, Kloke BP, Rengstl B, Battenberg M, Bonci F, Pistello M, Löchelt M, Cichutek K (2007): Multiple Restrictions of Human Immunodeficiency Virus Type 1 in Feline Cells.
J Virol 81: 7048-7060.

Nick S, Scheiblauer H (2007): Sensitivities of CE-marked HIV, HCV, and HBsAg assays.
J Med Virol 79: S59-S64.

Oertel K, Hunfeld A, Specker E, Reiff C, Seitz R, Pasternack R, Dodt J (2007): A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma.
Anal Biochem 367: 152-158.

Ohbayashi M, Manzouri B, Flynn T, Toda M, Ikeda Y, Nakamura T, Ono SJ (2007): Dynamic changes in conjunctival dendritic cell numbers, anatomical position and phenotype during experimental allergic conjunctivitis.
Exp Mol Pathol 83: 216-223.

Oricchio E, Sciamanna I, Beraldi R, Tolstonog GV, Schumann GG, Spadafora C (2007): Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression.
Oncogene 26: 4226-4233.

Osterloh A, Kalinke U, Weiss S, Fleischer B, Breloer M (2007): Synergistic and differential modulation of immune responses by Hsp60 and lipopolysaccharide.
J Biol Chem 282: 4669-4680.

Otto C, Wessler S, Fritzemeier KH: Exploiting nongenomic estrogen receptor-mediated signaling for the development of pathway-selective estrogen receptor ligands.
In: Korach KS., Wintermantel T. (Hrsg.), Tissue-Specific Estrogen Action: Novel Mechanisms, Novel Ligands, Novel Therapies 1. edition: Springer, 2007. 163-181. ISBN 3540495479
(Ernst Schering Foundation Symposium Proceedings 2006/1)

Pereira-Leal JB, Levy ED, Kamp C, Teichmann SA (2007): Evolution of protein complexes by duplication of homomeric interactions.
Genome Biol 8: R51.

Pillitteri D, Bassus S, Boller K, Mahnel R, Scholz T, Wegert W, Kirchmaier CM (2007): Thrombin-induced interleukin 1beta synthesis in platelet suspensions: impact of contaminating leukocytes.
Platelets 18: 119-127.

Popp SK, Mann DA, Milburn PJ, Gibbs AJ, McCullagh PJ, Wilson JD, Tönjes RR, Simeonovic CJ (2007): Transient transmission of porcine endogenous retrovirus to fetal lambs after pig islet tissue xenotransplantation.
Immunol Cell Biol 85: 238-248.

Poppe M, Feller SM, Römer G, Wessler S (2007): Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility.
Oncogene 26: 3462-3472.

Raut S, Merton RE, Rigsby P, Muszbek L, Seitz R, Ariens RA, Barrowcliffe TW, Ichinose A (2007): A collaborative study to establish the 1st International Standard for factor XIII plasma.
J Thromb Haemost 5: 1923-1929.

Reese G, Ballmer-Weber BK, Wangorsch A, Randow S, Vieths S (2007): Allergenicity and antigenicity of wild-type and mutant, monomeric and dimeric carrot major allergen Dau c 1: Destruction of conformation, not oligomerization is the roadmap to save allergen vaccines.
J Allergy Clin Immunol 119: 944-951.

Repanas K, Zingler N, Layer LE, Schumann GG, Perrakis A, Weichenrieder O (2007): Determinants for DNA target structure selectivity of the human LINE-1 retrotransposon endonuclease.
Nucleic Acids Res 35: 4914-4926.

Ring S, Weyer SW, Kilian SB, Waldron E, Pietrzik CU, Filippov MA, Herms J, Buchholz C, Eckman CB, Korte M, Wolfer DP, Muller U (2007): The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice.
J Neurosci 27: 7817-7826.

Rits MAN, van Dort KA, Münk C, Meijer AB, Kootstra N (2007): Efficient transduction of simian cells by HIV-1 based lentiviral vectors that contain mutations in the capsid protein.
Mol Ther 15: 930-937.

Rollier CS, Paranhos-Baccala G, Verschoor EJ, Verstrepen BE, Drexhage JA, Fagrouch Z, Berland JL, Komurian-Pradel F, Duverger B, Himoudi N, Staib C, Meyr M, Whelan M, Whelan JA, Adams VA, Larrea E, Riezu JI, Lasarte JJ, Bartosch B, Cosset FL, Spaan WJM, Diepolder HM, Pape GR, Sutter G, Inchauspe G, Heeney JL (2007): Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity.
Hepatology 45: 602-13.

Salge-Bartels U, Breitner-Ruddock S, Hunfeld A, Seitz R, Heiden M (2007): Reply to Svae et al. Letter to the Editor.
Transfus Med 17: 321.

Sanzenbacher R, Dwenger A, Schuessler-Lenz M, Cichutek K, Flory E (2007): European regulation tackles tissue engineering.
Nat Biotechnol 25: 1089-1091.

Schleicher U, Liese J, Knippertz I, Kurzmann C, Hesse A, Heit A, Fischer JA, Weiss S, Kalinke U, Kunz S, Bogdan C (2007): NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
J Exp Med 204: 893-906.

Schneider CK: EU Regulatory Guidelines and Advice on Working with Regulators.
In: Lyscom N (Hrsg.), Immunogenicity to Biologics: Impact on Product Development and Strategy for Assessment, Risk Management and Avoidance. London: Biopharm Knowledge Publ., 2007. 120-144.

Schneider CK, Kalinke U (2007): After the TGN1412 incident. Principles for assessment of first-in-man trials with monoclonal antibodies by the Paul Ehrlich Institute.
Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 50: 1213-1220.
Online-Abstract Text

Schneider CK, Löwer J: Safety Aspects of Biologics: Lessons Learnt from Monoclonal Antibodies.
In: Boehncke WH, Radeke H (Hrsg.), Biologics in General Medicine. Berlin: Springer, 2007. 169-174. ISBN 978-3-540-29017-9

Schürks M, Limmroth V, Geissler I, Tessmann G, Savidou I, Engelbergs J, Kurth T, Diener HC, Rosskopf D (2008): Association between migraine and the G1246A polymorphism in the hypocretin receptor 2 gene.
Headache 47: 1195-1199.

Schumann GG (2007): APOBEC3 proteins: major players in intracellular defence against LINE-1-mediated retrotransposition.
Biochem Soc Trans 35: 637-642.

Seitz R, von Auer F, Blümel J, Burger R, Buschmann A, Dietz K, Heiden M, Hitzler WE, Klamm H, Kreil T, Kretzschmar H, Nübling M, Offergeld R, Pauli G, Schottstedt V, Volkers P, Zerr I (2007): Impact of vCJD on blood supply.
Biologicals 35: 79-97.

Seitz R, Blümel J, Burger R, Drosten C, Gröner A, Gürtler L, Heiden M, Hitzler W, Jansen B, Klamm H, Ludwig WD, Montag-Lessing T, Offergeld R, Pauli G, Schlenkrich U, Schottstedt V, Willkommen H (2007): Arbobakterien (über Arthropoden übertragbare Bakterien).
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 50: 1192-1207.

Seitz R, Blümel J, Burger R, Drosten C, Gröner A, Gürtler L, Heiden M, Hildebrandt M, Jansen B, Klamm H, Montag-Lessing T, Offergeld R, Pauli G, Schlenkrich U, Schottstedt V, Schwaiger B, Willkommen H, Wirsing von König CH (2007): Influenzaviren.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 50: 1184-1191.

Selbitz HJ, Moos M (2007): Fledermäuse - Kein Ende der Tollwutbekämpfung?.
Kleintier konkret 5: 40-43.

Selbitz HJ, Moos M (2007): Zoonotische Colibakterien - Nach 100 Jahren - Gefahr erkannt.
Kleintier konkret 3: 29-32.

Siekmeier R, Halbauer J, Wetzel D (2007): Sicherheit von In-vitro-Diagnostika zum Gebrauch in der Transfusionsmedizin. Erfahrungen des BfArM bis Ende 2005.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 50: 1240-1248.

Simmons WM, Navratilova Z, Foster S, Roden D, Boller K, Murray PG, Nelson PN (2007): Optimal seeding concentrations of hybridomas and other novel strategies to enhance antibody yield.
Hum Antibodies 16: 159-162.

Sliva K, Schnierle B (2007): From actually toxic to highly specific - novel drugs against poxviruses.
Virol J 4: 8.

Spitzenberger F, Edelhäuser R, Funk M, Halbauer J (2007): Vigilance experience for high-risk IVDs in Europe.
RAJ Devices 15: 157-164.

Taylor A, Akdis M, Joss A, Wenig R, Colonna M, Daigle I, Flory E, Blaser K, Akdis C (2007): IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1.
J Allergy Clin Immunol 120: 76-83.

Thomas K, Bannon G, Herouet-Guicheney C, Ladics G, Lee L, Lee SI, Privalle L, Ballmer-Weber B, Vieths S (2007): The utility of an international sera bank for use in evaluating the potential human allergenicity of novel proteins.
Toxicol Sci 97: 27-31.

Thomas K, Herouet-Guicheney C, Ladics G, Bannon G, Cockburn A, Crevel R, Fitzpatrick J, Mills C, Privalle L, Vieths S (2007): Evaluating the effect of food processing on the potential human allergenicity of novel proteins: international workshop report.
Food Chem Toxicol 45: 1116-1122.

Toda M, Nakamura T, Ohbayashi M, Ikeda Y, Dawson M, Aye CC, Miyazaki D, Ono SJ (2007): Mechanisms of leukocyte trafficking in allergic diseases: insights into new therapies targeting chemokines and chemokine receptors.
Expert Review of Clinical Immunology 3: 351-364.

Überla K, Rosenwirth B, ten Haaft P, Heeney J, Sutter G, Erfle V (2007): Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy.
J Med Primatol 36: 2-9.

Ugurel S, Thirumaran RK, Bloethner S, Gast A, Sucker A, Mueller-Berghaus J, Rittgen W, Hemminki K, Becker JC, Kumar R, Schadendorf D (2007): B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis.
PLoS ONE 2: e236.

Waibler Z, Anzaghe M, Ludwig H, Akira S, Weiss S, Sutter G, Kalinke U (2007): Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
J Virol 81: 12102-12110.

Waibler Z, Detje CN, Bell JC, Kalinke U (2007): Matrix protein mediated shutdown of host cell metabolism limits vesicular stomatitis virus-induced interferon-alpha responses to plasmacytoid dendritic cells.
Immunobiology 212: 887-894.

Waibler Z, Kalinke U, Will J, Juan MH, Pfeilschifter JM, Radeke HH (2007): TLR-ligand stimulated interleukin-23 subunit expression and assembly is regulated differentially in murine plasmacytoid and myeloid dendritic cells.
Mol Immunol 44: 1483-1489.

Wallner M, Stöcklinger A, Thalhamer T, Bohle B, Vogel L, Briza P, Breiteneder H, Vieths S, Hartl A, Mari A, Ebner C, Lackner P, Hammerl P, Thalhamer J, Ferreira F (2007): Allergy multivaccines created by DNA shuffling of tree pollen allergens.
J Allergy Clin Immunol 120: 374-380.

Wangorsch A, Ballmer-Weber BK, Rösch P, Holzhauser T, Vieths S (2007): Mutational epitope analysis and cross-reactivity of two isoforms of Api g 1, the major celery allergen.
Mol Immunol 44: 2518-2527.

Waterkamp A, Haschberger B, Hesse J, Heiden M, Seitz R (2007): Bericht zur Meldung nach § 21 TFG für die Jahre 2003 und 2004.
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 50: 209-229.

Werner A, Binninger-Schinzel D, Müller D, Krause B, Meye B, Winskowsky G, Wolf T, Brodt R, Schnierle B (2007): Evolution of HIV Geno- and Phenotypes during Anti-Retroviral Therapy.
Eur J Med Res 12: 12-13.

Westritschnig K, Linhart B, Focke-Tejkl M, Pavkov T, Keller W, Ball T, Mari A, Hartl A, Stöcklinger A, Scheiblhofer S, Thalhamer J, Ferreira F, Vieths S, Vogel L, Böhm A, Valent P, Valenta R (2007): A Hypoallergenic Vaccine Obtained by Tail-to-Head Restructuring of Timothy Grass Pollen Profilin, Phl p 12, for the Treatment of Cross-Sensitization to Profilin.
J Immunol 179: 7624-7634.

Weydig C, Starzinski-Powitz A, Carra G, Löwer J, Wessler S (2007): CagA-independent disruption of adherence junction complexes involves E-cadherin shedding and implies multiple steps in Helicobacter pylori pathogenicity.
Exp Cell Res 313: 3459-3471.

Wolfrum N, Mühlebach MD, Schüle S, Kaiser JK, Kloke BP, Cichutek K, Schweizer M (2007): Impact of viral accessory proteins of SIVsmmPBj on early steps of infection of quiescent cells.
Virology 364: 330-341.

Yutzy B, Holznagel E, Coulibaly C, Stuke A, Hahmann U, Deslys JP, Hunsmann G, Löwer J (2007): Time-course studies of 14-3-3 protein isoforms in cerebrospinal fluid and brain of primates after oral or intracerebral infection with bovine spongiform encephalopathy agent.
J Gen Virol 88: 3469-3478.